サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624434

研究用抗体の世界市場規模：技術別、エンドユーザー別、製品別、用途別、地域別、範囲および予測

Global Research Antibodies Market Size By Technology, By End User, By Product, By Application, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
研究用抗体の世界市場規模：技術別、エンドユーザー別、製品別、用途別、地域別、範囲および予測
出版日: 2024年08月28日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

研究用抗体の市場規模と予測

研究用抗体市場規模は、2021年に108億7,000万米ドルと評価され、2023年から2030年にかけてCAGR 6.75%で成長し、2030年には195億5,000万米ドルに達すると予測されています。政府はプロテオミクスとゲノミクス研究に巨額の資金を提供しており、それが世界の調査抗体市場の急成長につながっています。研究用抗体の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

研究用抗体の世界市場定義

B細胞で構成されるタンパク質は抗体と呼ばれます。これらのB細胞は身体の免疫システムの一部です。抗体の主な機能は、抗原に取り付き、破壊のフラグを立てることです。これは感染症との戦いに役立ちます。研究用抗体は特定の分子に結合することができ、細胞研究における理想的なプローブとなります。研究用抗体は、細胞内のタンパク質機能を研究する上で重要なツールです。

研究用抗体の世界市場概要

研究用抗体の世界市場の成長は、研究活動の増加によって牽引されています。企業は研究開発活動に多額の投資を行っています。産学連携の活発化も研究用抗体の世界市場の急成長につながっています。インドや中国などの新興市場は、市場成長の新たな機会を生み出すと思われます。しかし、上記の促進要因とは逆に、市場成長を抑制する要因もあります。品質や結果の再現性の欠如に関する懸念は、市場の成長に悪影響を及ぼすと思われます。

目次

第1章 世界の研究用抗体市場のイントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の研究用抗体市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 規制の枠組み

第5章 研究用抗体の世界市場：技術別

  • ウェスタンブロッティング
  • フローサイトメトリー
  • 酵素結合免疫吸着測定法（ELISA）
  • 免疫組織化学
  • 免疫蛍光法
  • 免疫沈降
  • その他の技術

第6章 研究用抗体の世界市場：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 受託研究機関

第7章 研究用抗体の世界市場：製品別

  • 試薬
    • 培地・血清
    • 染色・色素
    • 固定化剤
    • 緩衝液
    • 溶媒
    • 酵素
    • プローブ
    • その他の試薬
  • 抗体
    • 種類別
    • ソース別
    • 研究分野別

第8章 研究用抗体の世界市場：用途別

  • プロテオミクス
  • 医薬品開発
  • ゲノミクス

第9章 研究用抗体の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第10章 世界の研究用抗体市場の競合情勢

  • 概要
  • 各社の市場シェア
  • ベンダー情勢
  • 主な開発戦略

第11章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Merck Group
  • Abcam PLC
  • Becton, Dickinson and Company
  • Cell Signaling Technology, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Lonza
  • Genscript
  • Perkinelmer, Inc.
  • Biolegend, Inc.

第12章 主な発展

  • 製品の上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第13章 付録

  • 関連調査
目次
Product Code: 24330

Research Antibodies Market Size And Forecast

Research Antibodies Market size was valued at USD 10.87 Billion in 2021 and is projected to reach USD 19.55 Billion by 2030, growing at a CAGR of 6.75% from 2023 to 2030. The governments are providing huge funds to proteomics and genomics research and that has led to the global Research Antibodies Market growing at a rapid pace. The Global Research Antibodies Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Research Antibodies Market Definition

The proteins which are made up of B cells are called antibodies. These B cells are part of the body's immune system. The primary function of the antibodies is to latch on to antigens and flag them for destruction. This helps in fighting infection. The research antibodies can bind specific molecules which makes them ideal probes in cell research. Research antibodies are an important tool when it comes to studying protein functions in cells.

Global Research Antibodies Market Overview

The growth of the Global Research Antibodies Market is being driven by increasing research activities. The companies are investing heavily in research and development activities. The growing industry-academia collaboration has also led to the rapid growth of the Global Research Antibodies Market. Emerging markets such as India and China will create new opportunities for the market to grow. However, contrary to the above drivers some restraints will limit the growth of the market. The concerns related to quality and lack of reproducible results will negatively influence the growth of the market.

Global Research Antibodies Market: Segmentation Analysis

The Global Research Antibodies Market is Segmented on the basis of Technology, End User, Product, Application, And Geography.

Research Antibodies Market, By Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

Based on Technology, the market is bifurcated into Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and Other Technologies. The flow cytometry segment is dominating the market owing to its ability to perform simultaneous multi-parameter analysis on a single cell within a heterogeneous mixture.

Research Antibodies Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Based on End User, the market is bifurcated into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies contributed majorly to the growth of the market as research antibodies are widely being used for drug development.

Research Antibodies Market, By Product

  • Reagents
  • Antibodies

Based on Product, the market is bifurcated into Reagents and Antibodies. The reagents segment is further bifurcated into Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, and Other Reagents. The antibodies segment is further bifurcated into By Type, By Source, and By Research Area.

Research Antibodies Market, By Application

  • Proteomics
  • Drug Development
  • Genomics

Based on Application, the market is bifurcated into Proteomics, Drug Development, and Genomics. The proteomics segment dominated the market as it was able to effectively minimize the cost, time, and resource requirement for chemical synthesis and biological testing of drugs.

Research Antibodies Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Research Antibodies Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America. The dominance of the North American region is credited to the increasing investment in the development of structure-based drug designs.

Key Players

  • The "Global Research Antibodies Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Thermo Fisher Scientific Inc., Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Danaher Corporation, Lonza, Genscript, Perkinelmer, Inc., Biolegend, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • In 2018, Thermo Fisher Scientific Inc., collaborated with Montreal Neurological Institute with an aim to develop improved and new methods to both characterize and produce antibodies for advanced neurological research associated with Amyotrophic lateral sclerosis, Parkinson's disease, and other brain diseases.
  • In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies.
  • Mergers and Acquisitions
  • On September 2018, Roche announced the acquisition of Tusk Therapeutic Ltd. Tusk is a developer of an antibody that has a novel mode of action aimed at depleting regulatory T cells.
  • In 2019, Thermo Fisher Scientific (US) acquired Brammer Bio (US) to expand its capacity for manufacturing viral vectors for gene and cell therapies with Brammer Bio's CDMO facilities. The acquisition was valued at USD 1.7 billion.
  • Product Launches and Product Expansions
  • On October 2021, Thermo Fisher Scientific, the world leader in serving science, has launched a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher's menu of highly accurate tests that detect active SARS-CoV-2 infections.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESEARCH ANTIBODIES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY

  • 5.1 Western Blotting
  • 5.2 Flow Cytometry
  • 5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 5.4 Immunohistochemistry
  • 5.5 Immunofluorescence
  • 5.6 Immunoprecipitation
  • 5.7 Other Technologies

6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER

  • 6.1 Pharmaceutical and Biotechnology Companies
  • 6.2 Academic and Research Institutes
  • 6.3 Contract Research Organizations

7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT

  • 7.1 Reagents
    • 7.1.1 Media & Sera
    • 7.1.2 Stains & Dyes
    • 7.1.3 Fixatives
    • 7.1.4 Buffers
    • 7.1.5 Solvents
    • 7.1.6 Enzymes
    • 7.1.7 Probes
    • 7.1.8 Other Reagents
  • 7.2 Antibodies
    • 7.2.1 By Type
    • 7.2.1.1 Primary Antibodies
    • 7.2.1.2 Secondary Antibodies
    • 7.2.2 By Source
    • 7.2.2.1 Mice
    • 7.2.2.2 Rabbits
    • 7.2.2.3 Other Sources
    • 7.2.3 By Research Area
    • 7.2.3.1 Oncology
    • 7.2.3.2 Infectious Diseases
    • 7.2.3.3 Immunology
    • 7.2.3.4 Neurobiology
    • 7.2.3.5 Stem Cells
    • 7.2.3.6 Other Research Areas

8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION

  • 8.1 Proteomics
  • 8.2 Drug Development
  • 8.3 Genomics

9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East and Africa

10 GLOBAL RESEARCH ANTIBODIES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Share
  • 10.3 Vendor Landscape
  • 10.4 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Thermo Fisher Scientific Inc.
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Merck Group
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Abcam PLC
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Becton, Dickinson and Company
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Cell Signaling Technology, Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Bio-Rad Laboratories, Inc.
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Agilent Technologies, Inc.
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Danaher Corporation
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 Lonza
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments
  • 11.11 Genscript
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.12 Perkinelmer, Inc.
    • 11.12.1 Overview
    • 11.12.2 Financial Performance
    • 11.12.3 Product Outlook
    • 11.12.4 Key Developments
  • 11.13 Biolegend, Inc.
    • 11.13.1 Overview
    • 11.13.2 Financial Performance
    • 11.13.3 Product Outlook
    • 11.13.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research